Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 17, 2021
Rentschler Biopharma announced the Company is establishing a Center of Excellence for cell and gene therapy, which will be located in Stevenage, UK.
read more
Wednesday, March 06, 2024
In 2023, the FDA Center for Drug Evaluation and Research (CDER) approved 55 new drugs, 17 of which were biopharmaceuticals. Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, ...
read more
Rentschler Biopharma announced the company has completed the acquisition of a manufacturing facility from an affiliate of Shire.
read more
Monday, November 21, 2022
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced, that following seven years of accelerated growth at Rentschler Biopharma under his leadership as Chief Executive ...
read more
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company has broken ground at its new production site, adjacent to its existing site in Milford, MA in the ...
read more
Wednesday, February 11, 2026
Rentschler Biopharma SE announced the appointment of Veit Bergendahl, PhD, as Chief Operating Officer (COO) and member of the Executive Board. He succeeds Christiane Bardroff, who has decided to pursue a new professional opportunity outside the ...
read more
Rentschler Biopharma appointed Mark Caswell as Vice President, Site Head. Mr. Caswell joined in July 2022 and is managing all operations at the company’s U.S. facilities in Milford, MA,
read more
Monday, November 18, 2019
Rentschler Biopharma announced the hiring of two executives for its facility in Milford, MA, USA, in the greater Boston area.
read more
Thursday, January 22, 2026
Rentschler Biopharma SE announced that Detra Glinatsis has rejoined the company as Head of Business Development U.S. In this newly created role, Ms. Glinatsis will lead all business development activities related to the U.S. market. She reports to Dr...
read more
Monday, December 04, 2023
Rentschler Biopharma SE has announced the appointment of Dr. Günter Stempfer as the Site Head for the company's facility in Laupheim, Germany, effective December 1, 2023.
read more
Rentschler Biopharma SE announced the appointment of Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026.
read more
Monday, September 13, 2021
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Dr. Christian Schetter, Ph.D. as Chief Scientific Officer (CSO) of Rentschler Biopharma SE, where ...
read more
Rentschler Biopharma SE announced that Patrick Cushing, Ph.D., has been promoted to Vice President Operations of Rentschler Biopharma, Inc., the company’s U.S. subsidiary, effective May 1, 2024. In this newly created position, Dr. Cushing will ...
read more
Rentschler Biopharma SE announced the appointment of Dr. Dominik Kugelstadt as Head of Clinical and Commercial Manufacturing, Laupheim, on July 1, 2023.
read more
Wednesday, January 30, 2019
Rentschler Biopharma announced the appointment of Dr. Christian Hunzinger as the new Senior Vice President Project Management, effective from January 15, 2019.
read more